Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
This trial update describes a pediatric brain tumor study using cerebrospinal fluid cell-free tumor DNA; the study was terminated.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma [Phase 1]
Phase 1 study evaluating vorasidenib in combination with pembrolizumab for recurrent or progressive IDH-1 mutant gliomas (astrocytoma and ol…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients [Phase 1]
A Phase 1 trial of the ADAGiO adoptive cellular therapy for adult patients with recurrent or progressive oligodendroglioma; the study is cur…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) [Phase 3]
Phase 3 trial SIGMA is investigating safusidenib as maintenance therapy for IDH1-mutant glioma and related astrocytoma/oligodendroglioma sub…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]
Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. [Phase 2]
A Phase 2 clinical trial update for pre-radiation chemotherapy in newly diagnosed high-grade gliomas, including glioblastoma, astrocytoma, a…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma [Phase 2]
Phase 2 clinical trial assessing the combination of All-Trans Retinoic Acid (ATRA) with a PD-1 inhibitor in recurrent IDH-mutant glioma; rec…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas [Phase 2]
A Phase 2 clinical trial from MD Anderson is evaluating chemotherapy and radiation therapy for IDH-wildtype gliomas and non-histological (mo…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma [Phase 1]
A Phase 1 clinical trial in pediatric patients with recurrent high-grade glioma evaluating hematopoietic stem cell therapy in combination wi…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms [Phase 1]
Phase I trial update indicates ONC206 is being studied for recurrent and rare primary central nervous system neoplasms and the study is curr…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation [Phase 2]
Phase 2 clinical trial update for vorasidenib in pediatric patients with IDH1/IDH2-mutant grade II astrocytoma or oligodendroglioma; the stu…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for relapsed/refractory intracranial glioma in patients under 22 years, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) [NA]
The HOBSCOTCH-CA trial, a home-based self-management and cognitive training program for brain cancer patients, is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of How Safe and Effective Tarlatamab is in Brain Cancers [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of tarlatamab in brain cancers is currently recruiting. The study targets ast…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: FearLess in NeuroOncology [NA]
Clinical trial update for FearLess in NeuroOncology indicates the study is currently recruiting for patients with glioblastoma and other pri…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
APPEAR is a clinical trial evaluating amino acid PET-based response assessment in IDH-mutant gliomas and is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Implantable Microdevice In Primary Brain Tumors [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating an implantable microdevice for primary brain tumors is currently recruiting across multiple gliom…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Study of Olutasidenib and Temozolomide in HGG [Phase 2]
Phase 2 study evaluating olutasidenib in combination with temozolomide for high-grade gliomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas [NA]
A clinical trial update for PRO-GLIO compares proton versus photon therapy in IDH-mutant diffuse gliomas and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of oral OKN-007 in adults with recurrent high-grade glioma. The trial includes patients …
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Update on the ProTRAIT proton therapy research infrastructure in neuro-oncology, with ongoing recruitment for several brain tumor conditions…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Abemaciclib in Patients with Oligodendroglioma [Phase 2]
Abemaciclib is being studied in a Phase 2 trial for adults with oligodendroglioma. The study is currently listed as active but not recruitin…
-
CLINICAL_TRIALS research · 2019-02-21Clinical Trial Update: A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas [Phase 2]
A Phase 2 prospective cohort study evaluating the effect of temozolomide on IDH-mutant low-grade gliomas (astrocytoma, oligodendroglioma, an…
-
CLINICAL_TRIALS research · 2017-06-08Clinical Trial Update: The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas
This document reports an update on using APT MRI to predict Bevacizumab efficacy in patients with recurrent malignant gliomas; the trial sta…
-
CLINICAL_TRIALS research · 2015-09-22Clinical Trial Update: FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Update on a clinical trial evaluating FET-PET imaging for diagnosis and monitoring of low-grade gliomas, including astrocytoma, oligodendrog…